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An efficient method for stable transfection of mouse myogenic
C2C12 cell line using a nonviral transfection approach
Mehmet Deniz AKYÜZ, Burcu BALCI HAYTA, Pervin R. DİNÇER

Aim: To describe in detail the use of the T-REx™ System (a tetracycline-regulated mammalian expression system;
Invitrogen) for rapid, easy, and effective generation of stable C2C12 cell clones. Tetracycline-inducible stable cell lines
are useful tools to study the function of various genes in different types of mammalian cells. However, the generation of
stable cell lines is a time-consuming, technically difficult, and expensive process.
Materials and methods: Generation of a stable C2C12 cell line was performed by stable transfection of the cells with
the pcDNA6/TR plasmid vector, which contains the tetracycline repressor and the blasticidin drug resistance genes. The
establishment of the stable cell line and the efficiency of the tetracycline-inducible gene expression system were shown
with the transient transfection of reporter plasmid pTO-EGFP and observation of the GFP expression by fluorescence
microscopy.
Results: We established a stable T-REx™ C2C12 cell line that can be used for muscle research studies by transfecting the
gene of interest with a second plasmid.
Conclusion: The T-REx™ system is useful in the development of stable cell lines for protein production or regulation of
gene expression.
Key words: C2C12 cell line, stable transfection, inducible expression, tetracycline resistance gene

C2C12 fare miyoblast hücre hattında viral olmayan transfeksiyon yöntemi ile kalıcı
transfeksiyonun gerçekleştirilmesi
Amaç: Tetrasiklinle uyarılabilir kalıcı hücre hatları, farklı memeli hücrelerindeki çeşitli genlerin fonksiyonunun
aydınlatılması amacıyla kullanılan yararlı bir araçtır. Ancak, kalıcı hücre hatlarının oluşturulması zaman alıcı, teknik
olarak zor ve pahalı bir süreçtir. Çalışmamızda, T-REx™ Systeminin (tetrasiklin ile uyarılabilir memeli gen ifade sistemi,
Invitrogen) kullanılması ile hızlı, kolay ve etkin olarak kalıcı transfekte edilmiş C2C12 hücre klonlarının oluşturulması
detaylı olarak anlatılmıştır.
Yöntem ve gereç: Kalıcı transfekte C2C12 hücre hattının oluşturulması; tetrasiklin represör ve blastisidin ilaç direnç
genlerini içeren pcDNA6/TR plazmid vektörünün hücrelere kalıcı transfeksiyonu ile gerçekleştirilmiştir. Kalıcı transfekte
hücre hattının kurulumu ve tetrasiklin ile uyarılabilir gen ifade sisteminin etkinliği; pTO-EGFP plazmid vektörünün
C2C12 hücrelerine geçici olarak transfeksiyonu sonrası GFP’nin ifadesinin floresan mikroskop ile gözlenmesi ile
gösterilmiştir.
Bulgular: Çalışmamızda, ilgilenilen genin ikinci bir plazmid ile transfekte edilmesi ile kas dokusu ile ilgili araştırmalarda
kullanılabilecek, kalıcı T-REx™ C2C12 hücre hattı oluşturulmuştur.
Sonuç: T-Rex™ sistemi ile oluşturulan kalıcı hücre hatları protein üretimi veya gen ifadesinin kontrolü için
kullanılabilmektedir.
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Introduction
The stable transfection method is used to
introduce recombinant DNA into eukaryotic cells
through integration into the host cells’ genomes.
It is widely used for versatile reasons such as gene
silencing, inducing the expression of a gene of
interest and observing the physiological effects of the
target protein, target validation, assay development,
and compound screening (1-4). There are many
different approaches for establishing stable cell lines,
depending on the type of expression (inducible
or constitutive) and the construct that is being
incorporated. Inducible expression systems are
widely used for controlling the dosage and temporal
expression of a given gene product in a population
of cells, either in tissue culture or in an intact
organism (5,6). Several inducible systems, based
on eukaryotic as well as prokaryotic regulatory
mechanisms, are available for research and potential
therapeutic applications. One of the most convenient
is the tetracycline-controlled transcription activation
system (Tet system) (7). The T-REx™ System
(Invitrogen) is a tetracycline-regulated mammalian
expression system that uses regulatory elements
from the E. coli Tn10-encoded tetracycline resistance
operon (8,9). Tetracycline regulation in the T-REx™
System is based on the binding of tetracycline to
the Tet repressor and derepression of the promoter
controlling the expression of the gene of interest. The
components of this system include the regulatory
plasmid (pcDNA6/TR) and the inducible plasmid
(pcDNA4/TO) (10). The repressor protein (TetR)
is expressed from the plasmid pcDNA6/TR and
binds to a specific DNA sequence, the Tet operator
site (TetO), in the absence of tetracycline, thus
preventing transcription of the gene of interest from
the second plasmid pcDNA4/TO. Upon addition,
tetracycline binds with high affinity to the TetR and
causes a conformational change in the repressor that
renders it unable to bind to the Tet operator. The Tet
repressor-Tet operator complex is unable to form and
this allows the transcription of the gene of interest.
Although there are many studies in which the
T-REx™ System was used to establish an inducible
expression (11,12), a detailed method is hard to find
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in research papers. In this study we present a detailed
and highly efficient method for stable transfection
of the mouse myogenic C2C12 cell line, which is a
well-established and useful model for the study of
myogenic differentiation, using the currently available
T-REx™ System. We generated stable C2C12 cell
clones with inducible expression of green fluorescent
protein (GFP). Using this system, a mouse-derived
C2C12 stable cell line was successfully generated.
Our method is simple, direct, and efficient.
Materials and methods
Cell culture conditions and transfection of
pcDNA6/TR into C2C12 cells
Myoblasts from the mouse skeletal muscle cell
line C2C12 (American Type Culture Collection,
Manassas, VA, USA) were grown on 35-mm2 culture
dishes (Falcon™). Cells (passage 7) were plated
at a density of 1 × 105 cells per well 24 h before
transfection, and were expanded in growth medium
consisting of DMEM with 10% fetal bovine serum
and 2 mM L-glutamine (complete medium) at 37
°C in 95% air and 5% CO2. C2C12 cells were then
transfected with pcDNA6/TR (Invitrogen) for 24 h
using FuGENE HD Transfection Reagent (Roche)
at a DNA (×1000 ng)-to-FuGENE HD (μL) ratio of
6:14. The pcDNA6/TR plasmid DNA was linearized
with SapI restriction enzyme prior to transfection.
In order to determine the transfection efficiency,
C2C12 cells were also transfected with pEGFP-C1
(Clontech). This was determined by counting GFPpositive cells and total cells from 6 random fields for
each condition. The transfection rate was defined as
the number of GFP-positive myoblasts divided by the
total number of myoblasts within the same field.
Selection of stably transfected cell lines
At 24 h after transfection, cultures were shifted to
complete medium containing 2 μg/mL of blasticidin
as a selective agent. At 18 days after transfection, cell
colonies were picked with cloning cylinders and split
into 60-mm petri dishes. Isolated clones were then
cultured and expanded. Nontransfected C2C12 cells
under the same conditions were used as experimental
controls.
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Immunofluorescence staining
Immunofluorescence staining was done on the
expanded clones and nontransfected control cells. Cells
on glass coverslips were fixed in 4% paraformaldehyde for
10 min, washed in 1 × PBS (pH 7.4) and permeabilized
with 0.2% Triton X-100 in 1 × PBS for 10 min, and
then blocked with 10% goat serum in 1 × PBS for 1
h. To detect the expression of TetR, transfected and
nontransfected control cells were immunostained by
rabbit anti-TetR antibody (1:500; MoBiTec) for 24 h at
+4 °C. Cells were then washed with 1 × PBS and labeled
with Alexa Fluor 488 goat antirabbit IgG (Molecular
Probes) at 1:1000 for 45 min at room temperature.
After washing in 1 × PBS, immunostained cells were
mounted and observed under an inverted fluorescent
microscopy (Leica DMIL). Appropriate excitation and
barrier filters were used to observe fluorescence.
Transfection of pTO-EGFP into C2C12 cells
The responsiveness of a tetracycline-sensitive
expression system was evaluated by transient
transfection of stably transfected clones with pTOEGFP at a DNA (×1000 ng)-to-FuGENE HD (μL)
ratio of 1:10. TetR promoter activation was achieved
24 h after transfection with the addition of 10 μg/mL
of tetracycline. Tetracycline (Sigma) responsiveness
was observed and photographed under an inverted
fluorescent microscopy (Leica DMIL).
Results and discussion
The transfer of foreign DNA into cultured cells
is an essential investigative tool for observing the
physiological effects of the change of expression
of a target gene (13). Control over the timing and
regulation of gene expression levels is essential for
both the in vitro and in vivo analysis of gene function
and gene therapy with safety and efficiency (14). This
control can be obtained with the use of inducible
expression systems (15). In this study, we used the
T-REx™ inducible expression system to generate a
stable C2C12 cell line. We used FuGENE HD, a lipidbased transfection reagent, to transfect the linearized
pcDNA6/TR plasmid into C2C12 cells. To determine
the transfection efficiency, C2C12 cells were also
transfected with pEGFP-C1 plasmid under the same

conditions. At 24 h after transfection, the transfection
efficiency was easily monitored and detected by
counting GFP-positive cells and total cells under a
microscope. We achieved a transfection efficiency of
approximately 70%.
At 18 days after transfection, 25 individual
blasticidin-resistant
clones
were
picked,
expanded, and screened for TetR expression by
immunofluorescence staining using the anti-TetR
polyclonal antibody (16). As shown in Figure 1, the
isolated blasticidin-resistant clone TR1 expressed
the TetR. In order to understand the tetracyclineinducible gene expression, we transfected the stably
transfected clones with the pTO-EGFP plasmid,
encoding GFP as a genetic marker. The transfection
efficiency was calculated as 40% by counting GFPpositive cells and total cells under a microscope. Out
of 25 clones, 4 showed inducibility with tetracycline.
As shown in Figure 2, the clone that showed the
maximum inducibility and minimum basal gene
expression (TR1) was chosen and expanded for
further studies.
The amount of the TetR produced from the
stable cell line is crucial for minimum background
gene expression and inducibility. A major drawback
of the T-REx™ system is the difficulty in obtaining
clones with high TetR expression. To overcome this
problem, different strategies, such as using different
reporter genes, replacing the TetR protein with a TetR
fusion protein to increase its affinity to the inducible
promoter, and the use of the Flp-In method for sitedirected transgene integration, have been proposed
(17-20). Considering that molecular engineering
strategies may take as long as clone screening,
and that the stable T-REx™ C2C12 cell line is not
commercially available, a stable C2C12 cell line is an
essential tool for muscle research.
We generated a stable T-REx™ C2C12 cell line,
which can be used for muscle research studies
by transfecting the gene of interest with a second
plasmid. Therefore, inducible gene expression can be
achieved with the inducing agent tetracycline. This is
extremely useful in situations where the product of
the gene of interest has a toxic or anti-mitotic effect.
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Figure 1. Immunodetection of the TetR in clone TR1. Immunofluorescent staining was performed with Anti-Tet-Repressor polyclonal
rabbit antibody (MoBiTec). Untransfected C2C12 cells were used as a negative control. Cells were also incubated with DAPI
to show the location of the nucleus. The cells were monitored under an inverted microscope. Bar: 0.1 mm.

Figure 2. Induction of clone TR1 with 10μg/mL of tetracycline. Left: Bright-field photomicrograph. Right: Fluorescence photomicrograph
of the induced TR1 clone expressing GFP reporter protein. Pictures were taken 24 h after induction with tetracycline under
an inverted microscope. Bar: 0.1 mm.
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